|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.03 USD | +5.12% |
|
+14.39% | -17.66% |
| 07-31 | Castle Biosciences, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-31 | Earnings Flash (CSTL) Castle Biosciences Posts Q2 Revenue of $103.5 Million, vs. FactSet Est of $86.2 Million | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 33.67 | 33.67 | 42.24 |
| Spread/Res. | -4.87% | -4.87% | -24.17% |
| Spread/Supp. | +17.80% | +76.47% | +67.43% |
| Support | 27.19 | 18.15 | 19.13 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CSTL Stock
- Charts Castle Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
